Bone Regeneration Articles & Analysis
20 news found
Sales of the material will begin in 2024 and will be distributed co-exclusively through CELLINK’s commercial channels. Bone regeneration is one of the fastest growing research disciplines, given the massive impact it can have on the overall quality of life. ...
ByCELLINK
OSSIO’s contract with Vizient covers the entire OSSIOfiber Intelligent Bone Regeneration Technology portfolio currently commercialized and cleared by the U.S. ...
This is the third FDA clearance for the company’s OSSIOfiber® Intelligent Bone Regeneration Technology, which uses proprietary bio-integrative material to provide stability and secure bone fixation while leaving no permanent hardware behind. ...
This experiment will examine the biomaterial's osteoconductivity when used in a microgravity environment where bone density and the ability to regenerate new bone tissue is significantly compromised. ...
Sam shares that “I am honored to have this opportunity to participate in bringing to market this exciting and rather unique bone regeneration platform technology, and to join a team that has developed this groundbreaking medical device. ...
Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. ...
Technology is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone Study will examine the safety and efficacy of ZetaMetTM in the treatment of metastatic bone lesions as part of advanced stage cancer therapy Study is targeting Stage 4 breast cancer patients who have metastatic lesions in their ...
Previously known as ZetaFuse™, ZetaMet™ is a synthetic, small-molecule, inductive biologic technology being developed to target and resolve metastatic bone lesions while inhibiting future tumor growth and regenerating bone. ...
CognitOss is a single-stage therapy that combines the local delivery of therapeutically appropriate levels of antibiotics from a ‘smart material’ that is designed to be responsive to the presence of infection and promote the regeneration of bone. It is designed to treat osteomyelitis, a debilitating inflammatory bone infection. ...
The patent, entitled Composition and Methods to Promote Bone Formation, covers the use of methods for stimulating bone growth using its small molecule, ZetaMet™. ...
Founded in 2014, NuShores is the licensee of UA Little Rock’s bone regeneration products, which have been developed primarily with DoD funding. ...
The RCSI licensing deal includes best in class, proprietary, natural collagen-based delivery technologies, which have been developed into products for the regeneration of bone, the treatment of infection and regeneration of cartilage tissues. Locate Bio’s ambition is to build a world leading, diversified orthobiologics company with a ...
The patent, entitled Composition and Methods to Promote Bone Formation, covers the use of methods for stimulating bone growth using the Company’s small molecule, ZetaMet™. ...
I am honored and excited to be a part of this revolutionary bone regeneration technology and to join a team that has developed this groundbreaking medical device as we manufacture the NuCress™ bone void filler scaffold product and other products based on this new technology. Mark Pelo, Manufacturing Manager About NuShores Biosciences LLC ...
HCCP technology serves as the platform for MMI’s bone regeneration product, Osteo-P™ Bone Graft Substitute (BGS). ...
-based biopharmaceutical company has discovered and patented a novel molecular pathway intended to treat metastatic bone lesions Latest patent issuance follows previous patents for methods in stimulating bone growth using ZetaMet™ New patent further enhances the Company’s Global IP strategy Zetagen Therapeutics, Inc., a private, US-based ...
Biomatlante, a world leader in synthetic bone regeneration technologies, is pleased to announce the obtention of the MDSAP* accreditation on the new ISO 13485:2016 Certificate. ...
These patents, entitled Composition and Methods to Promote Bone Formation, include claims covering the use of methods for stimulating bone growth using its novel molecular pathway, ZetaMet™. ...
Michal is currently working with supervisor Professor Sašo Ivanovski on the development of 3D printed scaffolds for bone and periodontal regeneration. ...
UA Little Rock wrote about us: https://ualr.edu/news/2018/09/20/nushores-biosciences-receives-1-7-million-grant-to-study-bone-regeneration-technology ...